Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Vgm Stock In Focus Buying Pressure Builds 20260401 1 Should I hold or sell BRC Group RILYG stock today NX Quanex Q1 2026 results outperform consensus EPS forecasts shares rise 35 percent on 438 percent year over year revenue gains HFRO Highland CEO names highyield credit assets as top strategic priority in latest quarterly earnings call First Trust Natural Gas ETF FCG NWAX New management outlines key upcoming merger timelines during its latest quarterly earnings call How Borealis BRLS builds value over time Bearish Sentiment 20260506 Centene Corporation CNC Dual Analyst Upgrades Reflect Bullish Outlook for Medicaid Margin Recovery Suburban SPH beats Q1 earnings estimates by 35 as revenue climbs 79 yearoveryear shares jump 3 Amazon Reports Record Thanksgiving Holiday Week Sales Highest Number of Items Sold Bruno Mars Matches Taylor Swifts Record on Billboard Radio Songs Chart Extending His Chart Dominance ColgatePalmolive India Shifts Focus to Premium Oral Care and Digital Execution for Growth BJs Restaurants Management to Present at Oppenheimer and Jefferies Investor Conferences Nuclear Startup Newcleo to Go Public on Nasdaq at 24 Billion Valuation Amazon Faces Allegations Over Millions Generated from NowIllegal Policy IPSC Q1 2026 Earnings EPS Beats Estimates Stock Declines Slightly as Pipeline Advances LivaNova LIVN Q1 2026 Earnings EPS Beats Estimates by 714 Amid Modest Stock Decline HCA Healthcare Inc Q1 2026 Earnings EPS Misses Estimates Amid Volume Growth and Cost Pressures AbbVie ABBV Q1 2026 Earnings Slight EPS Beat Amid Steady Performance IPST Q1 2026 Earnings Significant EPS Miss Raises Questions Sterling Infrastructure STRL Holds Steady as Key Technical Levels Come into Focus Waste Connections Inc WCN Holds Steady Near Resistance as Volume Remains Subdued SHFSW Warrants Slide 15 to 003 as Volatility Persists in MicroCap Trading NovaBay Pharmaceuticals NBY Surges Over 22 to 195 Amid Renewed Investor Interest Citius Pharmaceuticals CTXR Edges Higher as Trading Volume Remains Subdued